Munich Medical International

Prof. Dr. Frank Christ chairs the firm and serves as Managing Partner alongside Rolf Engel. Christ provides the clinical and academic underwriting grounded in LMU's medical research network. Engel's background in property development through International Campus GmbH suggests he leads real estate structuring and project execution. The partnership structure points to joint decision-making on new asset commitments.

MMI's origination model ties directly to Ludwig-Maximilians-Universität München. As an LMU spin-off, the firm accesses clinical networks, academic medical research departments, and hospital relationships that identify gaps in healthcare infrastructure. This relationship-based sourcing differentiates it from purely financial healthcare investors. Specific assets in Moscow and St. Petersburg indicate sourcing capability in Russian-language markets.

MMI's capital structure is not publicly detailed. It appears to develop assets on a project-specific basis rather than through traditional blind-pool fund structures. The firm's participation as a strategic partner in TVM Capital Healthcare's MENA I fund shows it co-invests alongside external managers. Whether MMI contributes balance-sheet capital or represents co-investors is not disclosed.

MMI is cited as a strategic partner and co-investor in the TVM Healthcare MENA I fund, a specialist vehicle targeting healthcare delivery and service investments in the Middle East and North Africa. The partnership marries TVM's emerging-market healthcare private equity expertise with MMI's European clinical and academic networks. Their co-investment model gives MMI exposure to healthcare assets beyond its direct Russian and European property portfolio.

The firm's known assets concentrate in Russia: the Moscow Clinical Scientific Center, the Narva Triumphal Arch Medical Center in St. Petersburg, and the Anapa Military Hospital project on the Black Sea coast. Through the TVM Healthcare MENA I partnership, MMI also has exposure to Middle Eastern and North African healthcare delivery investments. The Zurich headquarters suggests a European deal-sourcing and structuring base.